Automated Molecular Design and the BRADSHAW Platform
This presentation will describe how data-driven chemoinformatics methods may automate much of what has historically been done by a medicinal chemist. It will explore what is reasonable to expect “AI” approaches might achieve, and what is best left with a human expert.
The implications of automation for the human-machine interface will be explored and illustrated with examples from Bradshaw, GSK’s experimental automated design environment.
For more information about the Pistoia Alliance’s Artificial Intelligence project, please contact us.
We will email you the recording and slide deck.